Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 17;14(8):805.
doi: 10.3390/ph14080805.

Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Affiliations
Review

Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Enrique Ambrocio-Ortiz et al. Pharmaceuticals (Basel). .

Abstract

Angiotensin-Converting Enzyme 2 (ACE2) is an 805 amino acid protein encoded by the ACE2 gene expressed in various human cells, especially in those located in the epithelia. The primary function of ACE2 is to produce angiotensin (1-7) from angiotensin II (Ang II). The current research has described the importance of ACE2 and Ang (1-7) in alternative routes of the renin-angiotensin system (RAS) that promote the downregulation of fibrosis, inflammation, and oxidative stress processes in a great variety of diseases, such as hypertension, acute lung injury, liver cirrhosis, and kidney abnormalities. Investigations into the recent outbreak of the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have revealed the importance of ACE2 during infection and its role in recognizing viral binding proteins through interactions with specific amino acids of this enzyme. Additionally, the ACE2 expression in several organs has allowed us to understand the clinical picture related to the infection caused by SARS-CoV-2. This review aims to provide context for the functions and importance of ACE2 with regards to SARS-CoV-2 in the general clinical aspect and its impact on other diseases, especially respiratory diseases.

Keywords: Angiotensin-Converting Enzyme 2 (ACE2); Coronavirus disease 2019 (COVID-19); angiotensin; renin-angiotensin system (RAS); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The structure of ACE2. (A) Gene ACE2 conformed by 19 exons and 18 introns (3507 bp). (B) Alternative functional transcript without the last exon (3339). (C) Alternative transcript without the protein product (4 exons, 998 bp). (D) Alternative transcript without the protein product (3 exons, 786 bp). (E) Alternative transcript without the protein product (3 exons, 599 bp). Protein structure-based in PDB 1R42.
Figure 2
Figure 2
The organs and cells expressing ACE2.
Figure 3
Figure 3
Image of the possible substrates and products of Angiotensin-Converting Enzyme 2 (ACE2). ACE2 can affect Ang I and Ang II, producing Ang (1–9) and Ang (1–7), respectively. Ang (1–7) is a molecule with affinity for the Mas receptor (MasR), while Ang II is related to angiotensin II type 1 receptor (AT1R).
Figure 4
Figure 4
Regulated pathways of the nonclassical RAS axis. Angiotensin (1–7) (Ang (1–7)) can bind to Mas-related G-protein coupled receptor type D (MrgD) or Mas receptor (MasR). This interaction blocks the phosphorylation of the components of the two main pathways, Ras/Mitogen-activated protein kinase (MAPK) and Smad, resulting in the downregulation of apoptosis, cellular growth, tumor progression, inflammation, oxidative stress, reactive oxygen species, and mitochondrial stress. On the other hand, this interaction upregulates phosphatidylinositol-3-kinase (PI3K) to increase endothelial nitric oxide synthase (eNOS) phosphorylation, blocking the nicotinamide adenine dinucleotide phosphate reduced (NADPH) activity, decreasing the oxidative stress, and increasing the vasodilation. PLC: Phospholipase C; DAG: diacylglycerol; IP3: Inositol trisphosphate; IkB: inhibitor of nuclear factor kappa; NF-κB: nuclear factor kappa-light-chain-enhancer of activated B cells; IL-1β: interleukin 1 beta; TNF-α: Tumor necrosis factor alpha; Bcl2: B-cell lymphoma 2; Ras: Rat sarcoma virus; AP-1: activator protein 1; AKT1: AKT serine/threonine kinase 1; ROS: reactive oxygen species.
Figure 5
Figure 5
Classical and nonclassical renin-angiotensin (RAS) axes. Biological effects of the classical (ACE/Ang II/AT1R) and nonclassical (ACE2/Ang (1–7)/MasR) axes. IL-1β: interleukin 1 beta; TNF-α: Tumor necrosis factor alpha; Bcl2: B-cell lymphoma 2; IL-8: interleukin 8, TGF-β: Transforming growth factor beta; α-SMA: alpha smooth muscle actin; ROS: Reactive oxygen species; ERK1/2: extracellular signal-regulated protein kinase 1/2; NOS: Nitric oxide synthase.

References

    1. Gene ACE2 (ENSG00000130234)—Summary—Homo Sapiens—Ensembl Genome Browser 99. [(accessed on 25 March 2020)]; Available online: https://www.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000130....
    1. Zisman L.S., Keller R.S., Weaver B., Lin Q., Speth R., Bristow M.R., Canver C.C. Increased Angiotensin-(1–7)-Forming Activity in Failing Human Heart Ventricles: Evidence for Upregulation of the Angiotensin-Converting Enzyme Homologue ACE2. Circulation. 2003;108:1707–1712. doi: 10.1161/01.CIR.0000094734.67990.99. - DOI - PubMed
    1. Chen W.J., Liu H., Wang Z.H., Liu C., Fan J.Q., Wang Z.L., Xu Y.P., Zhang B., Gyawali L., Li Q., et al. The Impact of Renal Denervation on the Progression of Heart Failure in a Canine Model Induced by Right Ventricular Rapid Pacing. Front. Physiol. 2020;10:1625. doi: 10.3389/fphys.2019.01625. - DOI - PMC - PubMed
    1. Mukerjee S., Gao H., Xu J., Sato R., Zsombok A., Lazartigues E. ACE2 and ADAM17 Interaction Regulates the Activity of Presympathetic Neurons. Hypertension. 2019;74:1181–1191. doi: 10.1161/HYPERTENSIONAHA.119.13133. - DOI - PMC - PubMed
    1. Sharma N., Malek V., Mulay S.R., Gaikwad A.B. Angiotensin II Type 2 Receptor and Angiotensin-Converting Enzyme 2 Mediate Ischemic Renal Injury in Diabetic and Non-Diabetic Rats. Life Sci. 2019;235:116796. doi: 10.1016/j.lfs.2019.116796. - DOI - PubMed

LinkOut - more resources

-